Would-be partners wage angry feud

The angry exchanges between Emergent BioSolutions and Protein Sciences keep getting nastier.  Both companies now accuse each other of breaking their $78 million merger pact, and the accusations are likely to continue to ring in an ongoing lawsuit. This week Emergent revised its offer for Protein Sciences, but Protein Sciences says the deal is off. Report

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.